ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 23 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,964,000 | -6.3% | 4,900,000 | 0.0% | 0.01% | -8.3% |
| Q4 2020 | $5,295,000 | +4.6% | 4,900,000 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $5,064,000 | +14.8% | 4,900,000 | +22.5% | 0.01% | +7.7% |
| Q2 2020 | $4,410,000 | +8.9% | 4,000,000 | 0.0% | 0.01% | -13.3% |
| Q1 2020 | $4,048,000 | -29.0% | 4,000,000 | -20.0% | 0.02% | -16.7% |
| Q3 2019 | $5,702,000 | – | 5,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 9,821,000 | $11,314,000 | 1.07% |
| TFG Asset Management GP Ltd | 6,000,000 | $6,883,000 | 1.02% |
| Alken Asset Management Ltd | 400,000 | $461,000 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 6,525,000 | $7,470,000 | 0.54% |
| CSS LLC/IL | 8,000,000 | $9,158,000 | 0.51% |
| IRON Financial LLC | 505,000 | $578,000 | 0.28% |
| MACKAY SHIELDS LLC | 32,796,000 | $37,597,000 | 0.26% |
| OSTRUM ASSET MANAGEMENT | 400 | $459,000 | 0.22% |
| RWC Asset Management LLP | 4,400,000 | $5,037,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $5,580,000 | 0.16% |